Vionnie Yu

Vionnie Yu, Ph.D., serves as the Executive Director at Kelonia Therapeutics and is the Founder and Principal of Pegasus Consulting, where strategic business insights and scientific expertise are provided to various stakeholders in the pharmaceutical industry. Previously, Vionnie held the position of Senior Director of Biology at Mersana Therapeutics, directing antibody-drug conjugate discovery and spearheading multiple innovation programs. Prior to Mersana, Vionnie spent seven years at Novartis, where significant contributions included pioneering CRISPR-based therapies and establishing collaborations to advance cell therapeutics. Vionnie's academic background includes a Ph.D. in Human/Medical Genetics from McGill University and various executive strategy certifications from Harvard University.